Funding · Company
Bluejay Therapeutics, Inc.
San Mateo, CASoftware & Technology
Bluejay Therapeutics, Inc. of San Mateo, CA has disclosed $202M across 2 Form D offerings filed with the SEC between Aug 16, 2022 and May 10, 2024.
$202M
Total disclosed
2
Form D offerings
2019
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$20M
Form D · Aug 16, 2022 ↗
Q3 2022
· target $41M
Filing details
HeadquartersSan Mateo, CAIndustrySoftware & Technology (Other Technology)Incorporated2019SEC CIK0001868267Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →